A systematic review of quality of life in head and neck cancer treated with surgery with or without adjuvant treatment
S Rathod, J Livergant, J Klein, I Witterick, J Ringash - Oral oncology, 2015 - Elsevier
Quality of life (QoL) is an important consideration in the management of head and neck
cancers (HNC). We systematically reviewed the literature to assess the impact of curative …
cancers (HNC). We systematically reviewed the literature to assess the impact of curative …
Survivorship and quality of life in head and neck cancer
J Ringash - Journal of Clinical Oncology, 2015 - ascopubs.org
Head and neck cancer is becoming more common, and survival rates are improving. Human
papillomavirus–associated oropharyngeal cancer, in particular, is increasing in incidence …
papillomavirus–associated oropharyngeal cancer, in particular, is increasing in incidence …
A structured review of quality of life instruments for head and neck cancer patients
J Ringash, A Bezjak - Head & Neck: Journal for the Sciences …, 2001 - Wiley Online Library
Background Quality of life (QOL) is an important treatment outcome for head and neck
cancer. Our purpose was to critically review published disease‐specific QOL instruments. …
cancer. Our purpose was to critically review published disease‐specific QOL instruments. …
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non …
…, EM Sturgis, B Burtness, JA Ridge, J Ringash, J Galvin… - The Lancet, 2019 - thelancet.com
Background Patients with human papillomavirus (HPV)-positive oropharyngeal squamous
cell carcinoma have high survival when treated with radiotherapy plus cisplatin. Whether …
cell carcinoma have high survival when treated with radiotherapy plus cisplatin. Whether …
Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma
…, J Ringash, B Cummings, J Sykes… - Journal of Clinical …, 2013 - ascopubs.org
Purpose To describe outcomes of prospective trials of stereotactic body radiotherapy (SBRT)
for hepatocellular carcinoma (HCC). Patients and Methods Two trials of SBRT for patients …
for hepatocellular carcinoma (HCC). Patients and Methods Two trials of SBRT for patients …
[PDF][PDF] Deintensification candidate subgroups in human papillomavirus–related oropharyngeal cancer according to minimal risk of distant metastasis
…, I Weinreb, J Kim, J Ringash… - Journal of clinical …, 2013 - researchgate.net
… Int J Radiat Oncol Biol Phys 82:276-283, 2012 5. Spector ME, Gallagher KK, Light E, et al:
Matted nodes: Poor prognostic marker in oropharyngeal squamous cell carcinoma …
Matted nodes: Poor prognostic marker in oropharyngeal squamous cell carcinoma …
[PDF][PDF] Phase I study of individualized stereotactic body radiotherapy of liver metastases
…, R Wong, B Cummings, J Ringash… - Journal of clinical …, 2009 - scholar.archive.org
… Herfarth KK, Debus J, Wannenmacher M: Stereotactic radiation therapy of liver
metastases: Update of the initial phase-I/II trial. Front Radiat Ther Oncol 38:100-105, 2004 …
metastases: Update of the initial phase-I/II trial. Front Radiat Ther Oncol 38:100-105, 2004 …
[PDF][PDF] Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related …
…, L Tong, J Ringash, A Bayley, J Kim, A Hope, J Cho… - J Clin …, 2015 - researchgate.net
… Int J Radiat Oncol Biol Phys 82:276-283, 2012 17. O’Sullivan B, Huang SH, Siu LL, et al:
Deintensification candidate subgroups in human papillomavirusrelated oropharyngeal …
Deintensification candidate subgroups in human papillomavirusrelated oropharyngeal …
Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a …
…, A Trotti, J Bernier, J Bourhis, J Ringash… - Journal of Clinical …, 2010 - ascopubs.org
Purpose Promising results in a randomized phase II trial with the hypoxic cytotoxin tirapazamine
(TPZ) combined with cisplatin (CIS) and radiation led to this phase III trial. Patients and …
(TPZ) combined with cisplatin (CIS) and radiation led to this phase III trial. Patients and …
[PDF][PDF] Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma
…, B Cummings, J Kim, J Ringash… - Journal of Clinical …, 2009 - researchgate.net
Purpose A significant proportion of oropharyngeal squamous cell carcinomas (OSCC) are
associated with the human papilloma virus (HPV), particularly HPV16. The optimal method for …
associated with the human papilloma virus (HPV), particularly HPV16. The optimal method for …